Articles
20.04.2023
EU HTA and what it means for manufacturers

Oncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...

Read more
Articles
13.04.2023
What are Joint Scientific Consultations and why th...

We explore joint scientific consultations; what they mean and why they are important to manufacturer...

Read more
Articles
03.04.2023
What is the joint clinical assessment and what doe...

We explore what the joint clinical assessment (JCA) is, its process and what future developments may...

Read more
News
30.03.2023
PMA Insights: Week 13 SPECIAL EDITION – Worl...

We summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...

Read more
Insider Insights
14.03.2023
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
09.03.2023
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
09.03.2023
NICE issues conditional recommendation for digital...

NICE conditionally recommends eight digitally enabled therapies to treat depression and anxiety in a...

Read more
Articles
07.03.2023
Are acute therapies and curative drugs more afford...

We've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...

Read more
Insider Insights
02.03.2023
ABPI sets out new proposals in VPAG

ABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...

Read more
Insider Insights
24.02.2023
The EU has a new project to find payment models fo...

Project to help the EU develop new pricing and payment models to fund high-priced drugs and relieve ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.